Literature DB >> 33777625

Clinical Assessment and Lesion-Specific Management of Orbital Vascular Malformations.

Daniel B Rootman1, Stefania B Diniz1, Liza M Cohen1.   

Abstract

The systematic classification of vascular disease as proposed and refined by the International Society for the Study of Vascular Anomalies (ISSVA) divides vascular pathology first into tumors and malformations. Malformations are described as simple and complex, where simple malformations contain a single vascular system and complex malformations comprised of multiple vascular systems. Arteriovenous malformations are considered in terms of inflow characteristics which are primarily responsible for the key management challenges. Management utilizing endovascular embolization and/or surgical resection is often employed; however, recurrence can occur, particularly in diffuse cases. There may be an increasing role for systemic antiangiogenic therapy in such cases. Lymphaticovenous malformations are divided into the principle components on the lymphatic and venous sides for clarity of discussion. Lymphatic malformations are described morphologically as macrocystic and microcystic, and physiologically in terms of the processes responsible for growth. In both cases, surgical options are challenging and local therapeutics intended to close large luminal spaces in the case of macrocystic and to slow biological signaling for growth in microcystic. Venous malformations are described physiologically in terms of flow and distensibility, as volume plays a critical role in the limited space of the orbital cavity. Combined embolic-surgical approaches can be effective for management. More complicated, combined lesions can be managed by dividing the lesion into principal components and treating each appropriately. Thieme. All rights reserved.

Entities:  

Keywords:  arteriovenous malformations; interventional neuroradiology; intravascular embolization; lymphatic malformation; lymphaticovenous malformation; orbital neoplasms; sclerotherapy; venous malformations

Year:  2021        PMID: 33777625      PMCID: PMC7987384          DOI: 10.1055/s-0040-1722702

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  62 in total

1.  Sirolimus-induced regression of a large orbital lymphangioma.

Authors:  Wolf A Lagrèze; Lutz Joachimsen; Nikolai Gross; Christian Taschner; Jochen Rössler
Journal:  Orbit       Date:  2018-02-06

2.  Altered pigment epithelium-derived factor and vascular endothelial growth factor levels in lymphangioma pathogenesis and clinical recurrence.

Authors:  Douglas M Sidle; John Maddalozzo; Jason D Meier; Mona Cornwell; Veronica Stellmach; Susan E Crawford
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2005-11

3.  Prox1 function is required for the development of the murine lymphatic system.

Authors:  J T Wigle; G Oliver
Journal:  Cell       Date:  1999-09-17       Impact factor: 41.582

4.  An analysis of thirty cases of orbital lymphangioma. Pathophysiologic considerations and management recommendations.

Authors:  G J Harris; P J Sakol; G Bonavolontà; C De Conciliis
Journal:  Ophthalmology       Date:  1990-12       Impact factor: 12.079

5.  Sclerosing therapy as first line treatment for low flow vascular lesions of the orbit.

Authors:  Robert M Schwarcz; Guy J Ben Simon; Todd Cook; Robert A Goldberg
Journal:  Am J Ophthalmol       Date:  2006-02       Impact factor: 5.258

Review 6.  Hereditary hemorrhagic telangiectasia: an update on clinical manifestations and diagnostic measures.

Authors:  Haneen Sadick; Maliha Sadick; Karl Götte; Ramin Naim; Frank Riedel; Gregor Bran; Karl Hörmann
Journal:  Wien Klin Wochenschr       Date:  2006-03       Impact factor: 1.704

7.  Lymphographic-Like Technique for the Treatment of Microcystic Lymphatic Malformation Components of <3 mm.

Authors:  V Da Ros; M Iacobucci; F Puccinelli; L Spelle; G Saliou
Journal:  AJNR Am J Neuroradiol       Date:  2017-11-30       Impact factor: 3.825

8.  Notch1 and 4 signaling responds to an increasing vascular wall shear stress in a rat model of arteriovenous malformations.

Authors:  Jian Tu; Yang Li; Zhiqiang Hu
Journal:  Biomed Res Int       Date:  2014-01-20       Impact factor: 3.411

9.  Aberrant lymphatic endothelial progenitors in lymphatic malformation development.

Authors:  June K Wu; Christopher Kitajewski; Maia Reiley; Connie H Keung; Julie Monteagudo; John P Andrews; Peter Liou; Arul Thirumoorthi; Alvin Wong; Jessica J Kandel; Carrie J Shawber
Journal:  PLoS One       Date:  2015-02-26       Impact factor: 3.240

10.  An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study.

Authors:  Hanny Al-Samkari; Raj S Kasthuri; Joseph G Parambil; Hasan A Albitar; Yahya A Almodallal; Carolina Vázquez; Marcelo M Serra; Sophie Dupuis-Girod; Craig B Wilsen; Justin P McWilliams; Evan H Fountain; James R Gossage; Clifford R Weiss; Muhammad A Latif; Assaf Issachar; Meir Mei-Zahav; Mary E Meek; Miles Conrad; Josanna Rodriguez-Lopez; David J Kuter; Vivek N Iyer
Journal:  Haematologica       Date:  2021-08-01       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.